Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Cooney

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Hospital Topics|December 11, 2002
Hospital executive leadership: a critical component for improving care at the end of lifeJames P Cooney, Glenn M Landers, Julianna M Williams
The Biochemical Journal|March 4, 2022
Programmed cell death: the pathways to severe COVID-19?Stefanie M Bader, James P Cooney, Marc Pellegrini, et al.
Cell Death & Disease|January 29, 2024
Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivoStefanie M Bader, James P Cooney, Reet Bhandari, et al.
Cell Death and Differentiation|February 27, 2025
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signallingStefanie M Bader, Lena Scherer, Jan Schaefer, et al.
Cell Reports. Medicine|August 31, 2023
Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized micePhilip Arandjelovic, Youry Kim, James P Cooney, et al.
Nature Immunology|November 27, 2012
ARIH2 is essential for embryogenesis, and its hematopoietic deficiency causes lethal activation of the immune systemAmy E Lin, Gregor Ebert, Yongkai Ow, et al.
The Lancet. Microbe|September 18, 2023
Rapid detection of monkeypox virus using a CRISPR-Cas12a mediated assay: a laboratory validation and evaluation studySoo Jen Low, Matthew T O'Neill, William J Kerry, et al.
NPJ Vaccines|November 28, 2025
A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responsesVeronica P Zoest, Wen Shi Lee, Lydia Murdiyarso, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2023
SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlatesStefanie M Bader, James P Cooney, Dylan Sheerin, et al.
Frontiers in Chemistry|May 2, 2022
Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro InhibitorsDale J Calleja, Nathan Kuchel, Bernadine G C Lu, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Hospital Topics|December 11, 2002
Hospital executive leadership: a critical component for improving care at the end of lifeJames P Cooney, Glenn M Landers, Julianna M Williams
The Biochemical Journal|March 4, 2022
Programmed cell death: the pathways to severe COVID-19?Stefanie M Bader, James P Cooney, Marc Pellegrini, et al.
Cell Death & Disease|January 29, 2024
Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivoStefanie M Bader, James P Cooney, Reet Bhandari, et al.
Cell Death and Differentiation|February 27, 2025
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signallingStefanie M Bader, Lena Scherer, Jan Schaefer, et al.
Cell Reports. Medicine|August 31, 2023
Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized micePhilip Arandjelovic, Youry Kim, James P Cooney, et al.
Nature Immunology|November 27, 2012
ARIH2 is essential for embryogenesis, and its hematopoietic deficiency causes lethal activation of the immune systemAmy E Lin, Gregor Ebert, Yongkai Ow, et al.
The Lancet. Microbe|September 18, 2023
Rapid detection of monkeypox virus using a CRISPR-Cas12a mediated assay: a laboratory validation and evaluation studySoo Jen Low, Matthew T O'Neill, William J Kerry, et al.
NPJ Vaccines|November 28, 2025
A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responsesVeronica P Zoest, Wen Shi Lee, Lydia Murdiyarso, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2023
SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlatesStefanie M Bader, James P Cooney, Dylan Sheerin, et al.
Frontiers in Chemistry|May 2, 2022
Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro InhibitorsDale J Calleja, Nathan Kuchel, Bernadine G C Lu, et al.
Pageof 3